Hanwha Investment & Securities raised AmorePacific's target stock price to KRW 220,000.

Kim Minyoung / approved : 2024-04-30 09:12:21
  • -
  • +
  • 인쇄

View of AmorePacific headquarters. (Photo = AmorePacific)

 

[Alpha Biz= Reporter Kim Minyoung] Hanwha Investment & Securities raised AmorePacific's target stock price to KRW 220,000.

Hanwha Investment & Securities said, "AmorePacific's consolidated sales in the first quarter were 911.5 billion won and operating profit was 72.7 billion won, far exceeding the previous estimated operating profit of 54.2 billion won and consensus operating profit of 50.9 billion won."

Domestic cosmetics sales growth was slow, but domestic operating profit increased 36% due to luxury and premium brand-oriented growth and cost structure improvement. Overseas, sales in China fell 19% as sales of all brands declined due to the reduction of major channel inventory and the concentration of key products by brand.

However, due to the improvement of cost structure, operating profit in Asia turned into a surplus. In addition, sales of Laneige in EMEA and North America grew 102% and 55%, respectively, with overseas sales falling only 2%.

"We have raised the target price with the upward revision of the profit promotion policy," Hanwha Investment & Securities said. "In the past, the shift from department store and Free Standing Store-oriented channel structures to Multi Brand Shop and online channels has been completed, and the decrease in the absolute amount of depreciation has continued."

 

 

Alphabiz Kim Minyoung (kimmy@alphabiz.co.kr)

어플

주요기사

Bomb Threats Target Major Korean Companies Including Samsung Electronics2025.12.19
FSS Raises Consumer Alert to “Warning” Over Secondary Scams Linked to Coupang Data Breach2025.12.19
Final U.S. Defense Authorization Bill Omits Provisions Supporting South Korea-Japan Shipbuilding Cooperation2025.12.19
Controversy Surrounds KT’s Former Outside Director Cho Seung-ah Amid Dual Directorship Issue2025.12.19
Samsung Securities Lowers LG Energy Solution Target Price to KRW 480,000 Amid Contract Cancellations2025.12.19
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사